VIRPAX Trademark

Trademark Overview

On Friday, April 27, 2018, a trademark application was filed for VIRPAX with the United States Patent and Trademark Office. The USPTO has given the VIRPAX trademark a serial number of 87897821. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, April 11, 2025. This trademark is owned by Virpax Pharmaceuticals, Inc.. The VIRPAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical products development
virpax

General Information

Serial Number87897821
Word MarkVIRPAX
Filing DateFriday, April 27, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, April 11, 2025
Registration Number5627417
Registration DateTuesday, December 11, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 25, 2018

Trademark Statements

Goods and ServicesPharmaceutical products development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 7, 2018
Primary Code042
First Use Anywhere DateMonday, November 14, 2016
First Use In Commerce DateMonday, November 14, 2016

Trademark Owner History

Party NameVirpax Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355
Party NameVirpax Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355
Party NameVirpax Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355

Trademark Events

Event DateEvent Description
Tuesday, May 1, 2018NEW APPLICATION ENTERED
Monday, May 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, December 11, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 17, 2018ASSIGNED TO EXAMINER
Tuesday, August 21, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 25, 2018PUBLISHED FOR OPPOSITION
Tuesday, December 11, 2018REGISTERED-PRINCIPAL REGISTER
Monday, December 9, 2024TEAS SECTION 8 & 15 RECEIVED
Thursday, March 27, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 27, 2025POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Friday, April 4, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 4, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 4, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 4, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 4, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 4, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 4, 2025TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, April 11, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, April 11, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

virpax development products pharmaceutical